|
GRTX Galera Therapeutics Inc 1563577 |
| Balance Sheet |
|
Current Assets
|
8,899,000 |
|
Assets
|
8,901,000 |
|
Current Liabilities
|
914,000 |
|
Liabilities
|
151,963,000 |
|
Equity
|
-143,062,000 |
|
Shares Out
|
160,430,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-9,806,000 |
|
Investing Cash Flow
|
4,000 |
| Market Analysis |
Market Cap
|
16,283,620 |
|
Price
|
0.10 |
|
BVPS
|
0.27 |
|
PB
|
0.15 |
|
EPS
|
0.64 |
|
PE
|
0.16 |
|
PS
|
40.92 |
|
FCF
|
-9,802,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view GRTX documents filed with the SEC.
GRTX Filings
Clear